Open public hearings
This article was originally published in The Tan Sheet
Executive Summary
Individuals who wish to present during open public hearings at advisory committee meetings are not required to disclose financial ties, FDA says in a draft guidance published in the Federal Register Feb. 15. Although disclosure is encouraged, panelists should not ask further questions about a potential link, but may ask for further details on scientific content, the draft guidance adds...